UNSPSC 51182065: Prasterone sulfate

This classification denotes a therapeutic androgen C19H28O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 57B09Q7FJR, chemically known as androst-5-en-17-one, 3-(sulfooxy)-, (3.beta.)-, but more generally known as prasterone sulfate, which bears US NIH Compound Identifier 12594. European Medicines Agency schedules Prasterone sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34548. Most nations, for tariff and trade purposes, schedule prasterone sulfate under HS 29372900 and SITC 54153.

As of Q4 2014, PRASTERONE SULFATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C.

UNSPSC 51182065 Prasterone sulfate is a Commodity code covering a synthetic steroid pharmaceutical ingredient used in hormone replacement and related therapies. State and local governments procure this substance primarily through health departments, public health agencies, and state-operated or state-contracted clinics and medical facilities that dispense medications to qualifying populations. Purchasing typically occurs via RFQ or competitive bidding processes, often through established pharmaceutical supply agreements or cooperative purchasing vehicles that allow smaller jurisdictions to access negotiated pricing. The code applies to bulk pharmaceutical-grade prasterone sulfate supplied to public healthcare providers rather than to finished consumer medications or retail pharmacy distribution.

The source provides no recent state or local contract opportunities tagged to UNSPSC 51182065. Without posted solicitations to characterize issuing-body concentration, geographic spread, or procurement patterns, the code shows no current visibility in active state and local market activity tracked in this dataset.